SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008885
Filing Date
2017-11-14
Accepted
2017-11-14 08:01:02
Documents
49
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20170930x10q.htm 10-Q 1043438
2 EX-31.1 zyne-20170930ex311172209.htm EX-31.1 13573
3 EX-31.2 zyne-20170930ex312a66520.htm EX-31.2 13453
4 EX-32.1 zyne-20170930ex3219ade25.htm EX-32.1 6164
5 EX-32.2 zyne-20170930ex322a4bc78.htm EX-32.2 6160
  Complete submission text file 0001558370-17-008885.txt   3966586

Data Files

Seq Description Document Type Size
6 EX-101.INS zyne-20170930.xml EX-101.INS 833612
7 EX-101.SCH zyne-20170930.xsd EX-101.SCH 25667
8 EX-101.CAL zyne-20170930_cal.xml EX-101.CAL 30266
9 EX-101.DEF zyne-20170930_def.xml EX-101.DEF 108396
10 EX-101.LAB zyne-20170930_lab.xml EX-101.LAB 243372
11 EX-101.PRE zyne-20170930_pre.xml EX-101.PRE 207954
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 171198383
SIC: 2834 Pharmaceutical Preparations